SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-025705
Filing Date
2013-05-01
Accepted
2013-05-01 16:11:28
Documents
11
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v341882_10q.htm 10-Q 290439
2 EXHIBIT 31.1 v341882_ex31-1.htm EX-31.1 10663
3 EXHIBIT 31.2 v341882_ex31-2.htm EX-31.2 10610
4 EXHIBIT 32.1 v341882_ex32-1.htm EX-32.1 4378
5 EXHIBIT 32.2 v341882_ex32-2.htm EX-32.2 4320
  Complete submission text file 0001144204-13-025705.txt   2587770

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT chtp-20130331.xml EX-101.INS 261341
7 XBRL TAXONOMY EXTENSION SCHEMA chtp-20130331.xsd EX-101.SCH 33720
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE chtp-20130331_cal.xml EX-101.CAL 22518
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE chtp-20130331_def.xml EX-101.DEF 154266
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE chtp-20130331_lab.xml EX-101.LAB 241355
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE chtp-20130331_pre.xml EX-101.PRE 184150
Mailing Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277
Business Address 3530 TORINGDON WAY SUITE 200 CHARLOTTE NC 28277 704-341-1516
Chelsea Therapeutics International, Ltd. (Filer) CIK: 0001333763 (see all company filings)

IRS No.: 203174202 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51462 | Film No.: 13803290
SIC: 2836 Biological Products, (No Diagnostic Substances)